tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

DSS Finalizes Debt Conversion Agreement with Impact

Story Highlights
DSS Finalizes Debt Conversion Agreement with Impact

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

DSS ( (DSS) ) has issued an announcement.

On July 21, 2025, DSS, Inc. entered into a Debt Conversion Agreement with Impact Biomedical Inc. to settle a $12 million revolving promissory note originally issued in March 2023. This agreement involved DSS receiving 31,939,778 shares of Impact’s common stock, fully satisfying all outstanding debts and obligations owed by Impact to DSS, potentially impacting DSS’s financial position and stakeholder interests.

More about DSS

Average Trading Volume: 85,577

Technical Sentiment Signal: Sell

Current Market Cap: $10.55M

For a thorough assessment of DSS stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1